Adili Tsaba
Chief Tech/Sci/R&D Officer at VESSL Therapeutics Ltd.
Adili Tsaba active positions
| Companies | Position | Start | End |
|---|---|---|---|
VESSL Therapeutics Ltd.
 VESSL Therapeutics Ltd. Medical SpecialtiesHealth Technology VESSL Therapeutics Ltd. develops cell-based therapies for large patient populations. Its solutions include MultiGeneAngio fo Peripheral Artery Disease and MultiGeneGraft for end-stage renal disease. The company was founded in August 2000 by Moshe Y. Flugelman and Basil S. Lewis and is headquartered in Haifa, Israel. | Chief Tech/Sci/R&D Officer | 2000-12-31 | - |
| General Counsel | 2000-12-31 | - |
Career history of Adili Tsaba
Training of Adili Tsaba
| Technion-Israel Institute of Technology | Undergraduate Degree |
Statistics
International
| Israel | 3 |
Operational
| Chief Tech/Sci/R&D Officer | 1 |
| General Counsel | 1 |
| Undergraduate Degree | 1 |
Sectoral
| Health Technology | 2 |
| Consumer Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Private companies | 1 |
|---|---|
VESSL Therapeutics Ltd.
VESSL Therapeutics Ltd. Medical SpecialtiesHealth Technology VESSL Therapeutics Ltd. develops cell-based therapies for large patient populations. Its solutions include MultiGeneAngio fo Peripheral Artery Disease and MultiGeneGraft for end-stage renal disease. The company was founded in August 2000 by Moshe Y. Flugelman and Basil S. Lewis and is headquartered in Haifa, Israel. | Health Technology |
- Stock Market
- Insiders
- Adili Tsaba
- Experience
